Logo American Journal of Case Reports

Call: 1.631.629.4328
Closed: National Holiday

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

05 June 2023: Articles  Italy

A Multimodal Approach to Laser Treatment of Extensive Hypertrophic Burn Scar: A Case Report

Management of emergency care

Piero Campolmi1ABCDE, Lavinia Quintarelli ORCID logo2ABCDE, Irene Fusco3EF*

DOI: 10.12659/AJCR.939022

Am J Case Rep 2023; 24:e939022




BACKGROUND: Hypertrophic scars from severe burns cause physical and psychological stress. Proper treatment, including CO₂ laser systems, can alleviate these burdens by enabling skin remodeling and collagen production. This study assessed the efficacy of a new laser device with 2 wavelengths (10 600 nm/1540 nm) and 2 scanning units on hypertrophic burn scar management.

CASE REPORT: A 34-year-old African woman sought treatment for a large hypertrophic burn scar on her right foot. The scar, formed at age 9, was complicated by infection. She underwent 2 CO₂ sessions (Scar3 scanner), followed by 3 cycles of fractional CO₂ +1540 nm laser (µScan DOT scanner) once a month, combined with topical hyaluronic acid. She also had 2 maintenance sessions with a 595-nm dye laser to prevent scar reactivation. The CO₂ and 1540 nm laser synergy improved laxity through volumetric thermal effects, causing contraction and stimulation. This led to a softer, smaller scar with less consistency. The patient experienced significant improvement in quality of life due to alleviation of pain and restored footwear comfort.

CONCLUSIONS: The hypertrophic burn scar was effectively treated using 10 600 nm and 1540 nm wavelengths, along with dye laser treatment for recurrence prevention.

Keywords: Laser Therapy, Lasers, Dye, Lasers, Gas, Female, Humans, Child, Adult, Cicatrix, Hypertrophic, Treatment Outcome, Quality of Life, Carbon Dioxide, Hypertrophy, Burns


Hypertrophic scars are grave consequences of severe burn injuries, causing physical and psychological stresses. Adequate treatment can help alleviate these burdens. The literature contains negligible evidence supporting interventions for scar treatment. Although compression has been shown to be effective in reducing scarring [1], once the scar has developed, a more accurate evaluation of its effectiveness as a treatment option is required. There is a need to establish additional evidence-based treatment options for burn scars due to the difficulties in adhering to compression treatment regimens. To date, none of the other treatment options have undergone thorough evaluation by rigorous research studies; therefore, randomized, controlled, multicenter clinical trials are required to improve clinical care.

Surgical revision is an option for the most severely disabling scars, but the planning and choice of procedure are made on a case-by-case basis without consensus guidelines. Laser therapy, topical or intradermal pharmacotherapy (like corticosteroids), silicone gel and gel sheets, cutaneous radiation, systemic pharmacotherapy (eg, interferon), massage, and acupuncture are additional treatments that are currently being used in clinical settings, but these require more study. Massage therapy can improve scar pliability, pain, and pruritus, but with less supporting evidence [2]. The use of moisturizers and lotions can alleviate itching, but the findings are contradictory and the ideal moisturizer composition is unknown [3]. Particularly, the use of lasers as a form of treatment has grown in popularity [4].

Laser systems with CO2 sources enable skin remodeling by producing new collagen due to their dual ablative and thermal action [5–7]. Following treatment, invaginating epidermal cells completely replace the area where the fractional ablative laser caused immediate ablation at the epidermal/dermal level. The epidermal tissue is encircled by a microscopic ablative zone, and the stratum corneum contains microscopic epidermal necrotic debris (MEND). MEND begins to exfoliate on the seventh day, and 1 month after treatment, the normal stratum corneum replaces MEND [8]. As a result, these laser devices are effective in treating a wide range of imperfections and problems, including scarring and skin aging. By stimulating collagen and fibroblasts, fractional ablative CO2 lasers have proven to be a promising therapy for improving burn scar function/appearance and skin rejuvenation [9,10]. The 1540 nm wavelength is known to increase the expression of collagen-related synthesis genes while decreasing matrix protein production in cultured fibroblasts [11–14]. Recent scientific findings demonstrated that the simultaneous combination of the CO2 wavelength (10 600 nm) and the wavelength 1540 nm is a valid treatment choice for skin remodeling [15,16].

With these premises, the purpose of this study was to assess the efficacy of a new laser device (DuoGlide, Deka M.e.l.a Srl, Florence, Italy) in hypertrophic burn scar management using 2 recently developed scanning units. The first unit was the µScan DOT scanner, which combines a CO2 and 1540 nm with an estimated ablative DOT width of 120 µm @45 mJ of CO2 and 30 mJ@1540 nm [15]. The second was the Scar3 scanner, which uses a CO2 laser with an estimated ablative DOT width of 80 µm @45 mJ of CO2 [26]. In general, we combined 2 wavelengths, one with ablative activity and the other with thermal characteristics, to create a synergy that could amplify the benefits for the patient in terms of safety and efficacy. Specifically, the second wavelength of 1540 nm allows homogeneous and contiguous heating over the entire scan area, reaching significant depths in the dermis in a non-ablative way. Moreover, the sequential action of the CO2 laser with 1540 nm amplifies and improves the tissue thermal effect, as already demonstrated by previous histological studies [15]; it promotes more effective tissue remodeling, ensuring healing with the timings of a fractional emission.

Case Report

We present the case of a 34-year-old African female patient in good general health, with a body mass index (BMI) of 23.4 Kg/m2 and Fitzpatrick skin type VI, who came to our clinic for a large hypertrophic burn scar (HBS) extending from the plan-tar region to the inner arch part of the right foot. The scar formed following a burn that occurred at 9 years old and was later complicated by subsequent infection of the subcutaneous tissue. Afterwards, the scar underwent a progressive increase in size, thickness, and consistency. Over the years, the lesion resulted in a progressive functional limitation of the foot with associated pain while walking, leading to obvious claudication. In addition, the patient reported having a significant worsening of quality of life. Besides pain, it was related to embarrassment and the inability to wear open shoes comfortably. Multiple cycles of local and intralesional corticosteroids were performed before our visit, which lead to temporary relief of pain, but did not meaningfully improve the lesion’s size and consistency. With regards to the risks, benefits, and available treatment options, the patient’s informed consent was obtained. The first 2 monthly sessions were carried out using the CO2 wavelength (with a Scar3 scanner), to benefit from the greater deep ablative effect. Subsequently, we took advantage of the synergy emission of CO2 with 1540 nm to improve laxity, thanks to a greater volumetric thermal effect (with the µScan DOT scanner) causing contraction and stimulation as shown in Figure 1. After the first 2 CO2 treatments (Scar3) using a power of 25 W, spacing of 500 μm, stack 2, and pulse mode HP, the patient was treated with 3 cycles of fractional CO2 +1540 nm laser (µScan DOT) once a month, in association with topical hyaluronic acid (3 days of hyaluronic acid packs and greasy gauzes changed twice a day). One pass across the whole burn scar region was made, and both wavelengths simultaneously affected the skin. The laser settings were power of 15 W, spacing of 500 μm, Stack 2, pulse mode HP, power of 3 W, dwell time of 5 ms for the CO2 laser and 1540 laser, respectively. The treatment led to progressive scar improvement, making it softer on palpation and significantly reduced in size, in particular in the central area, with a gradual loss of consistency. Following the treatment, the patient reported noteworthy improvement in quality of life, thanks to pain alleviation and restored ability to wear any type of shoes without discomfort. Eventually, she was treated with 3 applications of a 595-nm dye laser (VasQ, Deka Mela srl) 1 month apart to avoid recurrences, with a fluence of 6.5 J/cm2 and a pulse width of 0.5 ms. The patient is currently undergoing 2 maintenance sessions with the dye laser to stop any reactivation of the scarring process.


The management of HBS represents a significant challenge for dermatologists. The use of fractional CO2 lasers is a viable option with durable results and can be used in difficult-to-treat areas, such as the soles, where repeated skin traumas provide the stimulus for continuous fibrotic tissue deposition [17]. The CO2 laser has several benefits, including quicker recovery time, less frequent need for anaesthesia, decreased thermal damage, lessened bleeding and inflammation, and almost no adverse effects (eg, unaesthetic scarring and dyschromic effects). These advantages must be considered if considering other surgical procedures, such as diathermocoagulation and traditional surgery, which involves more frequent unaesthetic use, protracted healing, and slower scarring processes, and a higher incidence of keloids and hypertrophic scars [10]. Due to their ablative and thermal effects, CO2-based light sources induce skin remodeling and neocollagenesis [10,26,15]. The fractional ablative CO2 laser has been increasingly used to treat burn scars [18,19]. A recent case study highlighted the success of combined medical and procedural treatment with fractional lasers for extensive hypertrophic burn scars, achieving good skin color and texture results [20]. The therapeutic efficacy of fractional CO2 laser for burns scars has also been recently shown in a meta-analysis by Mahar and co-workers [21], which reported a successful case of a large HBS managed using a fractional CO2 laser in combination with 1540 nm wavelength and dye laser. In terms of collagen remodeling and stimulation, the synergy of the 2 wavelengths improves the advantages already offered by the CO2 laser systems, with both skin tone strengthening and stimulation. Specifically, while CO2 acts fractionally, the second wavelength of 1540 nm, thanks to its special spatial shape, allows for homogeneous and contiguous non-coagulative heating over the entire scan area, reaching significant depths in the dermis (not gently reachable with the ablative laser alone without increasing the CO2 energy), in a non-ablative way.

A recently published study [22] evaluated the photobiomodulation effect of 1540 nm wavelength treatment on the proliferation of cultured fibroblasts and their ability to express type I and III collagen, showing promising results. Non-ablative fractional lasers stimulate wound healing, which can result in the remodeling of surgical and post-traumatic scar texture. This means the thermal injury induced by the laser is also controlled, resulting in a natural healing process that creates healthy new tissue. Consequently, an improvement in the skin appearance occurs without the risk of inflammation [23–25]. However, in some cases, reaching significant depths is necessary for effective hypertrophic scar remodeling. This can also result in an increase in the energies administered to the skin, which can cause hyperpigmentation (PIH) in response to skin damage. Indeed, excessive stimulation of melanocytes causes higher melanin synthesis. For this reason, a scanner that can minimize the risk of hyper- and hypo-pigmentation after treatment is mandatory. Indeed, thanks to its small micro-ablation width size (DOT) it can generate deeper ablative action using less energy. This kind of scanner has been designed specifically for the remodeling of deep scars, as already demonstrated by the excellent results of Scarcella et al [26].

Continuous technological research has reduced healing times while maintaining high clinical performance in recent decades. The use of a fractional laser causes numerous areas of micro-ablation DOT on the skin, with specific depths that can be adjusted by the operator and surrounded by vital tissue, reducing re-epithelialization time. Piccolo et al [27] found the combined use of CO2 and dye lasers to be an effective keloid treatment option providing excellent results. Their study treatment protocol caused the hypertrophic burn scar to gradually soften and shrink, especially in the central area. Along with a progressive loss of consistency that made the scar more palpable, the treatment led improvement in quality of life.


In this case, a significant scar reduction was achieved using combined laser treatment, which effectively enhances the healing of burn scars, thereby improving the patient’s psychological well-being and health-related quality of life. This case report demonstrates the potential for successful hypertrophic burn scar treatment using 2 laser wavelengths (10 600 nm and 1540 nm) and subsequent dye laser therapy to prevent recurrence. The study provides valuable clinical insights for innovative, early applications of non-ablative, dual-wavelength 10 600/1540 nm fractional lasers.

Limitations of our study include the absence of quantitative outcome measures. Future objectives encompass extending the follow-up period, increasing the number of cases, and developing a scale with a meaningful score range for burn scar evaluation.


1.. Brusselaers N, Pirayesh A, Hoeksema H, Burn scar assessment: A systematic review of different scar scales: J Surg Res, 2010; 164; e115-23

2.. Monstrey S, Middelkoop E, Vranckx JJ, Updated scar management practical guidelines: Non-invasive and invasive measures: J Plast Reconstr Aesthet Surg, 2014; 67(8); 1017-25

3.. Daly D, Janssens T, Van den Kerckhove E, Anthonissen , The effects of conservative treatments on burn scars: A systematic review: Review Burns, 2016; 42(3); 508-18

4.. Tredget EE, Shupp JW, Schneider JC, Scar management following burn injury: J Burn Care Res, 2017; 38(3); 146-47

5.. Reilly MJ, Cohen M, Hokugo A, Keller GS, Molecular effects of fractional carbon dioxide laser resurfacing on photodamaged human skin: Arch Facial Plast Surg, 2010; 12(5); 321-25

6.. Christiansen K, Bjerring P: Lasers Surg Med, 2008; 40; 454-60

7.. Prignano F, Campolmi P, Bonan P: Dermatol Ther, 2009; 22(Suppl. 1); S8-S15

8.. Reilly MJ, Cohen M, Hokugo A, Keller GS, Molecular effects of fractional carbon dioxide laser resurfacing on photodamaged human skin. Resurfacing on photodamaged human skin.: Arch Facial Plast Surg, 2010; 12; 321-25

9.. Bonan P, Campolmi P, Cannarozzo G, Eyelid skin tightening: A novel ‘Niche’ for fractional CO₂ rejuvenation: J Eur Acad Dermatol Venereol, 2012; 26(2); 186-93

10.. Campolmi P, Bonan P, Cannarozzo G: ScientificWorldJournal, 2012; 2012; 546528

11.. Tenna S, Cassotta G, Brunetti B, Persichetti P, Hyperpigmentated scars of the face following a toxic epidermal necrolysis (TEN): A case report: Dermatol Plast Surg, 2016; 1(2); 1-2

12.. Hopps E, Lo Presti R, Montana M, Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome: J Investig Med, 2013; 61; 978-83

13.. Menghini R, Uccioli L, Vainieri E, Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus: Acta Diabetol, 2013; 50; 907-10

14.. Ayuk SM, Abrahamse H, Houreld NN, Photobiomodulation alters matrix protein activity in stressed fibroblast cells in vitro: J Biophotonics, 2018; 11; e201700127

15.. Nisticò SP, Bennardo L, Zingoni T, Synergistic sequential emission of fractional 10.600 and 1540 nm lasers for skin resurfacing: An ex vivo histological evaluation: Medicina (Kaunas), 2022; 58(9); 1308

16.. Mezzana P, Valeriani M, Valeriani R, Combined fractional resurfacing (10600 nm/1540 nm): tridimensional imaging evaluation of a new device for skin rejuvenation: J Cosmet Laser Ther, 2016; 18(7); 397-402

17.. Zawahry BM, Sobhi RM, Bassiouny DA, Tabak SA: Controlled Clinical Trial J Cosmet Dermatol, 2015; 14(4); 324-31

18.. Klosová H, Zálešák B, Xinopulos P, Langová K: Acta Chir Plast, 2021; 63(4); 171-80

19.. Lee JH, Seo CE, Song WJ: Burns, 2021; 47(5); 1084-93

20.. Erickson T, Gray J, Tayebi B, Tung R, A multimodal approach to the treatment of extensive burn scars: A modified subcision technique for intralesional delivery of corticosteroid and 5-fluorouracil in combination with several procedural laser therapies; A case report: Scars Burn Heal, 2018; 4 2059513118818997

21.. Mahar PD, Spinks AB, Cleland H: J Burn Care Res 4, 2021; 42(2); 200-6

22.. Magni G, Piccolo D, Bonan P, 1540-nm fractional laser treatment modulates proliferation and neocollagenesis in cultured human dermal fibroblasts: Front Med (Lausanne), 2022; 9; 1010878

23.. Vasily DB, Cerino ME, Ziselman EM, Zeina ST, Non-ablative fractional resurfacing of surgical and post-traumatic scars: J Drugs Dermatol, 2009; 8(11); 998-1005

24.. Gronovich Y, Lotan AM, Treatment of scars with autologous fat grafting and 1540 nm non-ablative erbium laser: Yoav J Cosmet Laser Ther, 2022; 23; 1-4

25.. Haedersdal M, Moreau KER, Beyer DM, Fractional nonablative 1540 nm laser resurfacing for thermal burn scars: A randomized controlled trial: Surg Med, 2009; 41(3); 189-95

26.. Scarcella G, Pieri L, Fusco I, Skin fractional scar treatment with a new carbon dioxide scanner: Histological and clinical evaluation: Photobiomodul Photomed Laser Surg, 2022; 40(6); 424-32

27.. Piccolo D, Crisman G, Bovani B, Combined laser treatment for ear keloids: Case series: Comparison between two mini-invasive protocols: J Cosmet Dermatol, 2022; 21(1); 296-306

In Press

Case report  Congo, the Democratic Republic of the

A Rare Case of Hyperglycemia, Ketoacidosis, and Central Facial Paralysis in a Newly-Diagnosed Diabetic Woman

Am J Case Rep In Press; DOI: 10.12659/AJCR.942425  

Case report  China (mainland)

Intracranial Parasitic Fetus in a Living Infant: A Case Study with Surgical Intervention and Prognosis Anal...

Am J Case Rep In Press; DOI: 10.12659/AJCR.944371  

Case report  Jordan

Blue Toe Syndrome in Behçet’s Disease: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.943813  

Case report  South Korea

A Rare Case of Stroke in a 76-Year-Old Woman: Left Atrial Papillary Fibroelastoma as the Culprit

Am J Case Rep In Press; DOI: 10.12659/AJCR.943568  

Most Viewed Current Articles

07 Mar 2024 : Case report  USA 38,232

Neurocysticercosis Presenting as Migraine in the United States

DOI :10.12659/AJCR.943133

Am J Case Rep 2024; 25:e943133


10 Jan 2022 : Case report  Germany 31,087

A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...

DOI :10.12659/AJCR.935263

Am J Case Rep 2022; 23:e935263

19 Jul 2022 : Case report  Saudi Arabia 17,703

Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19

DOI :10.12659/AJCR.936128

Am J Case Rep 2022; 23:e936128

23 Feb 2022 : Case report  USA 17,653

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923